What Happened: Tilray reported third-quarter revenue of $188.34 million, up approximately 30% year-over-year. The number came in below the consensus estimate of $198.5 million, according to data ...

Here's why. Jim Cramer, host of CNBC's Mad Money, said on a recent show that it's time to buy shares of cannabis stock Tilray. Tilray has been making a series of strategic acquisitions ...

Tilray Brands stock was sliding after the marijuana company filed disappointing quarterly results and guidance. Tilray stock was tumbling 20% to $2.07 in Tuesday morning trading, while the S&P 500 ...

Tilray Brands' stock has plummeted from a $300 high in 2018 to just 61 cents, with short interest hitting a new high at the end of February. The company faces significant cash burn, leading to ...

Tilray stock has traded substantially higher as shares of other cannabis companies also spiked. Wall Street Memes assesses whether TLRY may present a good opportunity at current levels. TLRY has ...

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of ...

Claim your 7-Day free trial now. Tilray Brands, Inc. TLRY shares are trading nearly flat on Wednesday. The company’s stock is rising following two significant announcements today and yesterday.

Shares of Tilray Brands Inc. TLRY shed 3.94% to $0.81 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.37 ...

Shares of Tilray Brands (NASDAQ: TLRY) were flying higher on Wednesday. The company's stock gained 7.5% as of 2:25 p.m. ET but gained as much as 20% earlier in the day. The leg up comes as the S&P ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets.